Literature DB >> 21737666

Case report of a poorly differentiated uterine tumour with t(10;17) translocation and neuroectodermal phenotype.

Frédéric Amant1, Thomas Tousseyn, Lieve Coenegrachts, Jan Decloedt, Philippe Moerman, Maria Debiec-Rychter.   

Abstract

Endometrial stromal sarcoma (ESS) with primitive neuroectodermal differentiation is a very uncommon entity. Such a case presenting as stage IIIc (International Federation of Gynaecology and Obstetrics (FIGO) 2010) disease in a 51-year-old female is described. Microscopy suggested a small blue round cell tumour. Cytogenetic and multicolour fluorescent in situ hybridisation (M-FISH) analysis revealed a complex karyotype with the presence of unbalanced t(10;17)(q22;p13) translocation, indicating ESS. Peripheral Ewing´s sarcoma was excluded based on FISH and RT-PCR fusion transcripts analysis. After surgical staging, the patient received bleomycin-etoposide-cisplatin combination chemotherapy. A detailed analysis of the histopathology and genetic findings forms the basis of this report.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21737666

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

Review 1.  Recent advances in the histological and molecular classification of endometrial stromal neoplasms.

Authors:  Joana Ferreira; Ana Félix; Jochen K Lennerz; Esther Oliva
Journal:  Virchows Arch       Date:  2018-10-15       Impact factor: 4.064

2.  Macrophage infiltration and genetic landscape of undifferentiated uterine sarcomas.

Authors:  Joanna Przybyl; Magdalena Kowalewska; Anna Quattrone; Barbara Dewaele; Vanessa Vanspauwen; Sushama Varma; Sujay Vennam; Aaron M Newman; Michal Swierniak; Elwira Bakuła-Zalewska; Janusz A Siedlecki; Mariusz Bidzinski; Jan Cools; Matt van de Rijn; Maria Debiec-Rychter
Journal:  JCI Insight       Date:  2017-06-02

3.  Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement.

Authors:  Cheng-Han Lee; Rola H Ali; Marjan Rouzbahman; Adrian Marino-Enriquez; Meijun Zhu; Xiangqian Guo; Alayne L Brunner; Sarah Chiang; Samuel Leung; Nataliya Nelnyk; David G Huntsman; C Blake Gilks; Torsten O Nielsen; Paola Dal Cin; Matt van de Rijn; Esther Oliva; Jonathan A Fletcher; Marisa R Nucci
Journal:  Am J Surg Pathol       Date:  2012-10       Impact factor: 6.394

4.  The JAZF1-SUZ12 fusion protein disrupts PRC2 complexes and impairs chromatin repression during human endometrial stromal tumorogenesis.

Authors:  Xianyong Ma; Jinglan Wang; Jianhui Wang; Charles X Ma; Xiaobin Gao; Vytas Patriub; Jeffrey L Sklar
Journal:  Oncotarget       Date:  2017-01-17

5.  Uterine epithelioid leiomyosarcoma with c-kit expression and YWHAE gene rearrangement: a case report of a diagnostic pitfall of uterine sarcoma.

Authors:  Terufumi Kubo; Shintaro Sugita; Ryuichi Wada; Noriaki Kikuchi; Masahiro Iwasaki; Yumika Ito; Taro Sugawara; Hiromi Fujita; Makoto Emori; Ryoichi Tanaka; Hiroshi Hirano; Tsuyoshi Saito; Tadashi Hasegawa
Journal:  Diagn Pathol       Date:  2017-03-14       Impact factor: 2.644

Review 6.  Potential Therapeutic Targets in Uterine Sarcomas.

Authors:  Tine Cuppens; Sandra Tuyaerts; Frédéric Amant
Journal:  Sarcoma       Date:  2015-10-21

Review 7.  Endometrial Stromal Sarcomas: A Revision of Their Potential as Targets for Immunotherapy.

Authors:  Sandra Tuyaerts; Frédéric Amant
Journal:  Vaccines (Basel)       Date:  2018-08-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.